Zheng S, Song M, Wu L, Yang S, Shen J, Lu X, Du J, Wang W
School of Public Health and Family Medicine, Capital Medical University, Beijing, China.
Public Health Genomics. 2010;13(5):269-75. doi: 10.1159/000240969. Epub 2009 Sep 22.
China is a multicultural country that has arisen from its 56 ethnicities, with a diverse population of over 1.3 billion people and an imbalanced economic development. The health care system in China is tending to be overall funded through urban and rural health insurance plans. Although China has invested in the basic research of genome science, public health genomics-related programs and services in China started late. Prenatal screening is offered as part of routine clinical prenatal services and is free of charge in some economically advanced cities. Newborn screening programs are mandated throughout the country but vary between provinces and territories in terms of organization and diseases screened for; most screening tests are paid by out-of-pocket expenses. Genetic tests are encouraged while there are only one accredited state laboratory and few territorial laboratories in China. Further national genomics policies are needed in China in a range of genetic issues and infrastructure of public health genomics. Careful measurement is essential to understanding the nature and scale of the task ahead.
中国是一个由56个民族组成的多元文化国家，人口超过13亿，经济发展不平衡。中国的医疗保健系统倾向于通过城乡医疗保险计划进行整体资助。尽管中国已投资于基因组科学的基础研究，但中国与公共卫生基因组学相关的项目和服务起步较晚。产前筛查作为常规临床产前服务的一部分提供，在一些经济发达城市是免费的。全国都有新生儿筛查项目，但各省和地区在组织和筛查疾病方面存在差异；大多数筛查测试需自费支付。中国鼓励进行基因检测，但只有一家国家认可实验室，地区实验室也很少。在一系列基因问题和公共卫生基因组学基础设施方面，中国需要进一步的国家基因组学政策。仔细衡量对于了解未来任务的性质和规模至关重要。
